1
Errata Svensson, C. et al. Induction Chemotherapy and Radiotherapy in Loco-Regionally Advanced Epidermoid Carcinoma of the Anal Canal. Int. J. Radiat. Oncol. Biol. Phys. 41(4):863– 867;1998. An error has been detected in Table 2 on page 864. The proportion of males to females should be 3/28 not 4/28. The inconvenience to the reader is regretted. PII S0360-3016(98)00278-8 Ennis, R.D. et al. Changes in Biochemical Disease-Free Survival Rates as a Result of Adoption of the Consensus Conference Definition in Patients With Clinically Localized Prostate Cancer Treated With External-Beam Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 41:511–517;1998. The survival curves in Figure 2 were mislabeled. Given below is the figure with curves correctly labeled. Also the author would like to clarify that the “proposed definition of biochemical failure requires that each of the two PSA increases be greater than 0.03 ng/ml for the patient to be considered a failure on the basis of only two increases.” PII S0360-3016(98)00279-X Fig. 2. Kaplan-Meier biochemical disease-free survival rates according to the Consensus Conference definition and the Columbia-Presbyterian Medical Center definition for Gleason score 2– 6 patients. Int. J. Radiation Oncology Biol. Phys., Vol. 42, No. 2, p. 467, 1998 Copyright © 1998 Elsevier Science Inc. Printed in the USA. All rights reserved 0360-3016/98 $19.00 1 .00 467

document

Embed Size (px)

Citation preview

● Errata

Svensson, C.et al. Induction Chemotherapy and Radiotherapy in Loco-Regionally Advanced Epidermoid Carcinoma of theAnal Canal. Int. J. Radiat. Oncol. Biol. Phys. 41(4):863–867;1998.

An error has been detected in Table 2 on page 864. The proportion of males to females should be 3/28 not 4/28.

The inconvenience to the reader is regretted.

PII S0360-3016(98)00278-8

Ennis, R.D.et al.Changes in Biochemical Disease-Free Survival Rates as a Result of Adoption of the Consensus ConferenceDefinition in Patients With Clinically Localized Prostate Cancer Treated With External-Beam Radiotherapy. Int. J. Radiat.Oncol. Biol. Phys. 41:511–517;1998.

The survival curves in Figure 2 were mislabeled. Given below is the figure with curves correctly labeled.

Also the author would like to clarify that the “proposed definition of biochemical failure requires that each of the two PSAincreases be greater than 0.03 ng/ml for the patient to be considered a failure on the basis of only two increases.”

PII S0360-3016(98)00279-X

Fig. 2. Kaplan-Meier biochemical disease-free survival rates according to the Consensus Conference definition and theColumbia-Presbyterian Medical Center definition for Gleason score 2–6 patients.

Int. J. Radiation Oncology Biol. Phys., Vol. 42, No. 2, p. 467, 1998Copyright © 1998 Elsevier Science Inc.Printed in the USA. All rights reserved

0360-3016/98 $19.001 .00

467